Keep up to date with the latest developments at CDISC and follow our news feeds!
22 Jun 2017 | Jason Monteleone, President, Pivotal Financial Consulting, LLC | Clinical Leader

15 Jun 2017 | Rob DiCicco, VP, Clinical Innovation and Digital Platforms, GSK | Clinical Leader

13 Jun 2017

TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6, 2017. Qualified researchers and clinicians are encouraged to review TAUG-DMD v1.0 and offer feedback.

17 May 2017

CDISC served as a key stakeholder, providing input to the development of Common Protocol Template (CPT). CPT aligns with NIH/FDA-developed Template connecting the parallel universes of clinical care and research as stated by FDA Commissioner during the CDISC/FDA strategy session in August 2016.

9 May 2017 | Various | Alzheimer’s & Dementia: Translational Research & Clinical Interventions

9 May 2017 | Kit Howard, Director, Education, CDISC and Shannon Labout, VP, Education, CDISC | Interchange Poster

18 Apr 2017

Austin, TX – 18 April 2017– The Clinical Data Interchange Standards Consortium (CDISC) today announced the release of Major Depressive Disorder (MDD) Therapeutic Area User Guide v1.0. The MDD standard is freely available on the CDISC website. Therapeutic Area User Guides provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, enabling smarter research to unlock cures.

10 Apr 2017

CDISC Contact:

Andrea Vadakin


Austin, TX – 10 April 2017 – The Clinical Data Interchange Standards Consortium (CDISC) announced that David R. Bobbitt, MSc, MBA will join CDISC as its new Chief Executive Officer today. Mr. Bobbitt succeeds Dr. Rebecca Daniels Kush, CDISC Founder, who completed her 20-year tenure as CDISC President this month. 

30 Mar 2017

CDISC Contact:

Andrea Vadakin




Austin, TX – 30 March 2017 – The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the participation of high-level representatives from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), the Japan Pharmaceuticals and Medical Devices Agency (PMDA), and the Infectious Diseases Data Observatory (IDDO) at the 2017 CDISC Europe Interchange. Participating global regulators will provide discussion around regulatory requirements for use of the CDISC standards that went into effect at the end of last year. Also participating in the conference will be CDISC experts and innovators from industry and academia. This educational and networking conference will be held 24-28 April in London, England.

28 Mar 2017




CDISC Contact:

Andrea Vadakin



WWARN Contact:

Anne Whitehouse

+44 (0)1865 612948